Cannabinoid receptors in microglia of the central nervous system: immune functional relevance
- PMID: 16204639
- DOI: 10.1189/jlb.0405216
Cannabinoid receptors in microglia of the central nervous system: immune functional relevance
Abstract
Microglia, resident macrophages of the brain, function as immune effector and accessory cells. Paradoxically, they not only play a role in host defense and tissue repair but also have been implicated in a variety of neuropathological processes. Microglia, in addition to exhibiting phenotypic markers for macrophages, express CB1 and CB2 cannabinoid receptors. Recent studies suggest the existence of a third, yet-to-be cloned, non-CB1, non-CB2 cannabinoid receptor. These receptors appear to be functionally relevant within defined windows of microglial activation state and have been implicated as linked to cannabinoid modulation of chemokine and cytokine expression. The recognition that microglia express cannabinoid receptors and that their activation results in modulation of select cellular activities suggests that they may be amenable to therapeutic manipulation for ablating untoward inflammatory responses in the central nervous system.
Similar articles
-
Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.J Neurochem. 2005 Oct;95(2):437-45. doi: 10.1111/j.1471-4159.2005.03380.x. Epub 2005 Aug 8. J Neurochem. 2005. PMID: 16086683
-
Cannabinoid system and neuroinflammation: implications for multiple sclerosis.Neuroimmunomodulation. 2007;14(3-4):182-7. doi: 10.1159/000110644. Epub 2007 Dec 5. Neuroimmunomodulation. 2007. PMID: 18073512 Review.
-
Therapeutic potential of cannabinoid receptor ligands: current status.Methods Find Exp Clin Pharmacol. 2006 Apr;28(3):177-83. doi: 10.1358/mf.2006.28.3.985231. Methods Find Exp Clin Pharmacol. 2006. PMID: 16810344 Review.
-
Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.Ann N Y Acad Sci. 2006 Aug;1074:514-36. doi: 10.1196/annals.1369.052. Ann N Y Acad Sci. 2006. PMID: 17105950 Review.
-
CB1 and CB2 cannabinoid receptor expression during development and in epileptogenic developmental pathologies.Neuroscience. 2010 Sep 29;170(1):28-41. doi: 10.1016/j.neuroscience.2010.07.004. Epub 2010 Jul 13. Neuroscience. 2010. PMID: 20621164
Cited by
-
Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and δ opioid systems.J Neurochem. 2013 Mar;124(6):808-20. doi: 10.1111/jnc.12139. Epub 2013 Jan 31. J Neurochem. 2013. PMID: 23286559 Free PMC article.
-
Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB2 receptor agonist ABK5.J Pharmacol Sci. 2021 Apr;145(4):319-326. doi: 10.1016/j.jphs.2020.12.006. Epub 2020 Dec 29. J Pharmacol Sci. 2021. PMID: 33712283 Free PMC article.
-
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.J Neuroinflammation. 2012 Jan 16;9:8. doi: 10.1186/1742-2094-9-8. J Neuroinflammation. 2012. PMID: 22248049 Free PMC article.
-
Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain.Int J Mol Sci. 2022 Apr 15;23(8):4407. doi: 10.3390/ijms23084407. Int J Mol Sci. 2022. PMID: 35457225 Free PMC article. Review.
-
Oleanolic Acid Exerts a Neuroprotective Effect Against Microglial Cell Activation by Modulating Cytokine Release and Antioxidant Defense Systems.Biomolecules. 2019 Nov 1;9(11):683. doi: 10.3390/biom9110683. Biomolecules. 2019. PMID: 31683841 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical